Brivaracetam
NDC 14335-420, brivaracetam, injection, from Hainan Poly Pharm. Co., Ltd..
- Product NDC
- 14335-420
- Status
- Listed
- Labeler
- Hainan Poly Pharm. Co., Ltd.
- Dosage form
- INJECTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA218249
- DEA schedule
- CV
curl https://api.healthcare.dev/v1/drugs/ndc/14335-420 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- BRIVARACETAM50 mg/5mL
Pharmacologic classes
Epoxide Hydrolase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 14335-420-10 | 14335042010 | 10 VIAL, GLASS in 1 CARTON (14335-420-10) / 5 mL in 1 VIAL, GLASS (14335-420-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/3ea51292-fe03-46f5-9d9b-36986f5b7224
Use it
Look up 14335-420 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/14335-420 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 14335-420. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.